Mount Sinai researchers have published the first study to use wearable devices to assess how inflammation and symptoms in ...

Cedars-Sinai investigators have developed an investigational therapy that brought a significant number of patients with ...

New basic science insights into programmed cell death could offer relief for inflammatory bowel disease. Many people with IBD ...

This retrospective cohort study identified several dietary compounds, specifically fatty acids, that are associated with ...

Pediatric infliximab biosimilar use has risen significantly, reflecting evolving treatment patterns in inflammatory bowel ...

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by ...

Patients with inflammatory bowel disease may be twice as likely to develop rheumatoid arthritis than those without IBD.

Kelsey Sharma, a nurse practitioner based in Minnesota, presents her research on the relationship between OSA, GERD, and IBD ...

Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease ...

Subcutaneous infliximab therapy alone is associated with higher immunogenicity than IV infliximab and an immunomodulator combined.

Crohn's disease is an inflammatory bowel disease that commonly affects the intestines and large intestines. It is an auto-immune disease that has no specific causing agent. An auto-immune disease ...